Publicacions en col·laboració amb investigadors/es de Instituto Valenciano de Oncologia (21)

2021

  1. Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC)

    Actas Urologicas Espanolas, Vol. 45, Núm. 2, pp. 93-102

  2. Head and neck cancer in times of COVID-19: Emotion-based medicine

    Acta Otorrinolaringologica Espanola

2020

  1. Consensus Document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on Tracheotomy in Patients with COVID-19 Infection

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 67, Núm. 9, pp. 504-510

  2. Consensus document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on tracheotomy in patients with COVID-19 infection

    Medicina Intensiva, Vol. 44, Núm. 8, pp. 493-499

  3. Consensus document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on tracheotomy in patients with COVID-19 infection

    Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 6, pp. 386-392

  4. Prognostic factors in patients with vulvar cancer: The VULCAN study

    International Journal of Gynecological Cancer, Vol. 30, Núm. 9, pp. 1285-1291

  5. Recommendations of the Spanish Society of Otolaryngology and Head and Neck Surgery for performing tracheotomies in patients infected by the coronavirus, Covid-19

    Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 4, pp. 253-255

2019

  1. Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance

    Prostate Cancer and Prostatic Diseases, Vol. 22, Núm. 1, pp. 84-90

2017

  1. Erratum to: “Study protocol and pathology report standardization of intermediate potential and malignant soft tissue tumours in adolescents and adults” [Rev Esp Patol 50 (2) (2017) 100–112](S1699885517300016)(10.1016/j.patol.2016.12.003)

    Revista Espanola de Patologia

  2. Lymphovascular space invasion for endometrial cancer: Undertreatment and overtreatment risks: A survey of the Spanish gynecologic oncology group

    International Journal of Gynecological Cancer, Vol. 27, Núm. 6, pp. 1191-1199

  3. Protocol for the study of bone tumours and standardization of pathology reports

    Revista Espanola de Patologia

  4. Protocolo de estudio y estandarización del informe patológico de los tumores de partes blandas malignos y de comportamiento intermedio de adolescentes y adultos

    Revista Espanola de Patologia

  5. The management of active surveillance in prostate cancer: Validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry

    Oncotarget, Vol. 8, Núm. 65, pp. 108451-108462

2016

  1. Prognostic factors of recurrence and survival in vulvar melanoma

    International Journal of Gynecological Cancer, Vol. 26, Núm. 7, pp. 1307-1312

2015

  1. Sequential combination of mitomycin C plus bacillus calmette-guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: Final outcome of CUETO 93009, a randomized prospective trial

    European Urology, Vol. 67, Núm. 3, pp. 508-516

  2. Spanish consensus on premature menopause

    Maturitas, Vol. 80, Núm. 2, pp. 220-225

2014

  1. Multicenter study of outcome in relation to the type of resection in rectal cancer

    Diseases of the Colon and Rectum, Vol. 57, Núm. 7, pp. 811-822

2013

  1. Tratamiento del tumor vesical no músculo infiltrante frente al problema de disponibilidad de bacilo de Calmette-Guerin. Consenso de un panel de expertos españoles

    Actas Urologicas Espanolas, Vol. 37, Núm. 7, pp. 387-394

2009

  1. Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

    Journal of Urology, Vol. 182, Núm. 5, pp. 2195-2203

2007

  1. A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C

    European Urology, Vol. 52, Núm. 5, pp. 1398-1406